MakeO Raises $10M to Expand Zenyum’s Dental Network Across Asia
MakeO, the parent company of dental and oral-care platform Zenyum, has raised $10 million to expand across Asia and pursue acquisitions.
Researching dental technology?
Compare 824+ dental vendors by category, use case, integrations, and fit.
Investment firm Singularity AMC led the primary investment round. MakeO's transaction adviser also identified DSP Family Office and individual angel investors as participants. The company did not disclose a new valuation.
What Happened
MakeO operates the Toothsi clear-aligner brand in India and became the parent of Singapore-based Zenyum earlier in 2026.
The combined group now works with approximately 1,100 partner dentists across India, Singapore, Malaysia, Vietnam, Taiwan, Hong Kong and Japan. Reuters reported that the group has exceeded S$70 million—about $54.7 million—in annual recurring revenue and is profitable on an EBITDA basis.
The new capital is intended to:
- expand Zenyum's partner-dentist network across Southeast and North Asia;
- strengthen shared technology systems;
- increase manufacturing capacity; and
- support additional acquisitions in India and other Asian markets.
MakeO manufactures clear-aligner products near Mumbai and sells them through Toothsi in India and Zenyum across Southeast and North Asia.
Why It Matters
This is more than a financing round for a regional aligner brand.
MakeO and Zenyum are assembling a cross-border dental platform that combines consumer acquisition, partner-dentist distribution, technology and manufacturing. The funding is designed to reinforce all four layers.
That model matters to dental operators and investors because it shows how scale can be built across fragmented markets without owning every clinical location. A network of partner dentists gives the platform clinical reach, while centralized technology, manufacturing and consumer brands provide operating leverage.
The group is also pursuing acquisitions rather than relying solely on organic growth. That makes the raise both growth capital and potential transaction capital.
The Post-Merger Integration Test
MakeO agreed to acquire Zenyum earlier this year, creating a group spanning India, Southeast Asia and North Asia.
The strategic logic is clear: Toothsi contributes Indian scale and manufacturing infrastructure, while Zenyum contributes a wider regional dentist network and consumer presence.
The operating challenge is integration.
A cross-border dental platform must coordinate different regulatory environments, clinical workflows, consumer expectations and local dentist relationships. Shared technology can create efficiency, but only if it improves the experience for both clinicians and patients rather than adding another administrative layer.
The use of proceeds suggests MakeO understands that the merger is not complete merely because ownership has changed. Capital is being directed toward the systems and capacity required to make the combined platform function at larger scale.
What the Market Should Watch
Five developments will indicate whether the strategy is working:
- Dentist-network growth: How quickly does Zenyum add active partner dentists across its existing markets?
- Manufacturing utilization: Can the Mumbai facility support regional growth without compromising turnaround time or product consistency?
- Technology integration: Do Toothsi and Zenyum move toward a shared clinical, ordering and patient-management infrastructure?
- Acquisition targets: Will MakeO buy local clinics, dental brands, manufacturing capabilities or technology?
- Unit economics: Can the group maintain EBITDA profitability while funding expansion across multiple countries?
Avized Take
The $10 million amount is meaningful, but the more important signal is the platform it supports.
MakeO and Zenyum are combining manufacturing, consumer brands, technology and a large partner-dentist network under one dental group. The company is already reporting more than $54 million in annual recurring revenue and positive EBITDA, giving it a stronger base for consolidation than an early-stage expansion story would suggest.
For dental investors, the next question is whether MakeO can turn a portfolio of regional assets into a genuinely integrated operating platform. If it can, the group could become an important consolidator across Asian dental care and oral health.
Sources: Reuters, October 13, 2026 and Touchstone Partners deal announcement, October 13, 2026.
Related resources
Avized Weekly
Get this kind of analysis every Wednesday.
Independent dental vendor intel — new profiles, comparisons, and market trends.
Browse the full dental AI database
824 vendors profiled, compared, and ranked by data — not marketing spend.
Browse vendors